Back to Overview
Dr. Martin Fabry
Martin Fabry completed his bachelor’s degree in Molecular Biomedicine at the University of Bonn in 2014 and subsequently moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York), where he worked on improving CRISPR/Cas9 technologies. In 2016, he obtained a master’s degree in Life and Medical Sciences with a focus on molecular mechanisms of immunity, before starting his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge, where he studied genome organisation and stability.
After receiving his doctorate in 2020, Martin worked as a postdoctoral fellow in computational biology at the Gurdon Institute and the European Bioinformatics Institute (EBI) in Cambridge, focusing on stem cell development and the establishment of new technologies for stem cell differentiation.
Martin is a registered German and European Patent and Trademark Attorney, and became Managing Director of IP2 in early 2025.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
Russian Warship…
...Go F**k yourself! … was the final communication made on 24 February, the first day of the 2022 Snake Island campaign, by Ukrainian border guard Roman Hrybov to the Russian missile cruiser Moskva just before the ship opened fire on Sevastopol. The phrase went viral...
Dr. Dietmar Pressner – New Kid on the Block
Introducing Dr. Dietmar Pressner We proudly announce that Dr. Dietmar Pressner has joined our IP2 team as a Senior Patent Advisor, responsible for chemical cases and IP strategy. Originally qualified as a PhD. in Chemistry completed at the Max Planck Institute for...
Nagoya Protocol 2.0
Additional New White Paper from IP2 concerning the Nagoya Protocol Our white paper "10 years of the Nagoya Protocol" from late 2023 explains the background, summarizes the current implementation into national law and provides an overview of the requirements that...
Back to Overview